Producer
New England Biolabs (NEB)
Private biotechnology company founded 1974; Ipswich, Massachusetts; the world's leading reference supplier of Taq polymerase and PCR enzyme reagents for research; NEB's M0267 Taq polymerase is the most widely cited in scientific literature; also produces Q5 high-fidelity polymerase, OneTaq, LongAmp Taq, and Luna reverse transcriptase master mixes; NEB enzymes are used as quality standards and positive controls in clinical diagnostic assay development; private ownership by employee-shareholders makes it independent of public market pressures; ~5-8% of global PCR enzyme market
1
Inputs supplied
1
Goods downstream
1
Facilities
0
Stories
What they make
1 input New England Biolabs (NEB) supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something New England Biolabs (NEB) makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
PCR Enzymes & Reagents
45%Restriction Enzymes
20%Cloning & Assembly
15%RNA Biology & NGS
20%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2023
NEB's molecular biology enzyme portfolio supplies: mRNA vaccine manufacturing (T7 RNA polymerase for in vitro transcription of mRNA, capping enzymes, reverse transcriptases); forensic DNA analysis (Taq polymerase for STR profiling in criminal investigations and paternity tests); agricultural biotech research (restriction enzymes, ligases for plant genetic engineering); and environmental DNA (eDNA) monitoring for biodiversity assessment. The same NEB Taq polymerase vial used by a molecular biology student to amplify DNA for a class experiment is the same enzyme used by the FBI Forensic Science laboratory to amplify DNA evidence from crime scenes, by Pfizer's manufacturing QC team to verify mRNA integrity, and by Dow AgroSciences researchers to confirm transgene integration in herbicide-resistant soybeans. NEB's open commercial model made it the universal reference supplier for an enzyme that touches criminal justice, vaccine safety, food security, and environmental science simultaneously.
New England Biolabs Inc. ↗Origin2023
New England Biolabs was founded in 1974 in Beverly, Massachusetts by Don Comb, a molecular biologist who wanted to build a research reagent company based on scientific rigor and open culture rather than proprietary secrecy. NEB established its reputation by characterizing restriction enzymes with extraordinary precision and publishing the data openly -- in an era when other companies guarded enzyme characterization as trade secrets. The company remains privately owned and employee-stock-plan eligible, with the founding Comb family maintaining long-term control. NEB's approach -- price reasonably, characterize thoroughly, share freely -- built extraordinary loyalty from academic researchers who then became the procurement decision-makers when they moved to biotech companies. By the time mRNA vaccine technology needed a curated, quality-verified enzyme toolkit in 2020, NEB's reference enzymes for reverse transcription, T7 transcription, and capping were the established standard that Pfizer, Moderna, and BioNTech trusted for their manufacturing process development.
New England Biolabs Inc. ↗